Endocannabinoid System: behavioral modulation in murine models by Cannabinoids type 2 receptors





Cannabinoid receptor type 2; Endocannabinoid system; Behavioral modulation; Mood disorders; CB2R target drugs; Behavioral tests.


In the last decades, the eCB system has been highlighted by its neuro and immunomodulatory effects. Beyond CB1R effects in Central Nervous System (CNS), CB2R target drugs has been showed to be promising to mitigation of neuroinflammatory diseases in mouse models. However, it remains unknow the effects of CB2R target drugs on behavior. Therefore, we review the effects of CB2R on behavior in murine models by Pubmed website, selecting studies between 2001 to 2021. In this sense, many studies has demonstrated the effects of overexpression, lack, activation or antagonization of CB2R on Aggressive behavior, Memory-associated behaviors, Mood disorders and Reward behavior. Similarly, it is not clear yet how the eCB system modulates the behavior through CB2Rs present in neurons. Thus, in mouse models, although the pharmacological treatment with CB2R target drugs seems to be promising for neuroinflammatory diseases, on behavior there are few answers about the pathways of this modulation, as well as, it is fundamental the development and/or the update of behavioral tests that evaluate many parameters, then expose better interpretations in these tests.


Bahi, A., Al Mansouri, S., Al Memari, E., Al Ameri, M., Nurulain, S. M., & Ojha, S. (2014). beta-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice. Physiol Behav, 135, 119-124. 10.1016/j.physbeh.2014.06.003

Basu, S., & Dittel, B. N. (2011). Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease. Immunol Res, 51(1), 26-38. 10.1007/s12026-011-8210-5

Borner, C., Smida, M., Hollt, V., Schraven, B., & Kraus, J. (2009). Cannabinoid receptor type 1- and 2-mediated increase in cyclic AMP inhibits T cell receptor-triggered signaling. J Biol Chem, 284(51), 35450-35460. 10.1074/jbc.M109.006338

Castillo, P. E., Younts, T. J., Chavez, A. E., & Hashimotodani, Y. (2012). Endocannabinoid signaling and synaptic function. Neuron, 76(1), 70-81. 10.1016/j.neuron.2012.09.020

Chen, D. J., Gao, M., Gao, F. F., Su, Q. X., & Wu, J. (2017). Brain cannabinoid receptor 2: expression, function and modulation. Acta Pharmacol Sin, 38(3), 312-316. 10.1038/aps.2016.149

Concannon, R. M., Okine, B. N., Finn, D. P., & Dowd, E. (2015). Differential upregulation of the cannabinoid CB(2) receptor in neurotoxic and inflammation-driven rat models of Parkinson's disease. Exp Neurol, 269, 133-141. 10.1016/j.expneurol.2015.04.007

Ehrhart, J., Obregon, D., Mori, T., Hou, H., Sun, N., Bai, Y., & Shytle, R. D. (2005). Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation. J Neuroinflammation, 2, 29. 10.1186/1742-2094-2-29

Ennaceur, A., & Chazot, P. L. (2016). Preclinical animal anxiety research - flaws and prejudices. Pharmacol Res Perspect, 4(2), e00223. 10.1002/prp2.223

Garcia-Gutierrez, M. S., Garcia-Bueno, B., Zoppi, S., Leza, J. C., & Manzanares, J. (2012). Chronic blockade of cannabinoid CB2 receptors induces anxiolytic-like actions associated with alterations in GABA(A) receptors. Br J Pharmacol, 165(4), 951-964. 10.1111/j.1476-5381.2011.01625.x

Estrela, C. (2018). Metodologia científica: ciência, ensino, pesquisa. Artes Médicas.

Garcia-Gutierrez, M. S., Ortega-Alvaro, A., Busquets-Garcia, A., Perez-Ortiz, J. M., Caltana, L., Ricatti, M. J., & Manzanares, J. (2013). Synaptic plasticity alterations associated with memory impairment induced by deletion of CB2 cannabinoid receptors. Neuropharmacology, 73, 388-396. 10.1016/j.neuropharm.2013.05.034

Gertsch, J., Leonti, M., Raduner, S., Racz, I., Chen, J. Z., Xie, X. Q., & Zimmer, A. (2008). Beta-caryophyllene is a dietary cannabinoid. Proc Natl Acad Sci U S A, 105(26), 9099-9104. 10.1073/pnas.0803601105

Harkany, T., Guzman, M., Galve-Roperh, I., Berghuis, P., Devi, L. A., & Mackie, K. (2007). The emerging functions of endocannabinoid signaling during CNS development. Trends Pharmacol Sci, 28(2), 83-92. 10.1016/j.tips.2006.12.004

Hashiesh, H. M., Meeran, M. F. N., Sharma, C., Sadek, B., Kaabi, J. A., & Ojha, S. K. (2020). Therapeutic Potential of beta-Caryophyllene: A Dietary Cannabinoid in Diabetes and Associated Complications. Nutrients, 12(10). 10.3390/nu12102963

Kim, J., & Li, Y. (2015). Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission. J Physiol, 593(4), 871-886. 10.1113/jphysiol.2014.286633

LeGates, T. A., Kvarta, M. D., Tooley, J. R., Francis, T. C., Lobo, M. K., Creed, M. C., & Thompson, S. M. (2018). Reward behaviour is regulated by the strength of hippocampus-nucleus accumbens synapses. Nature, 564(7735), 258-262. 10.1038/s41586-018-0740-8

Li, Y., & Kim, J. (2016a). CB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory. Neural Plast, 2016, 9817089. 10.1155/2016/9817089

Li, Y., & Kim, J. (2016b). Deletion of CB2 cannabinoid receptors reduces synaptic transmission and long-term potentiation in the mouse hippocampus. Hippocampus, 26(3), 275-281. 10.1002/hipo.22558

Li, Y., & Kim, J. (2017). Distinct roles of neuronal and microglial CB2 cannabinoid receptors in the mouse hippocampus. Neuroscience, 363, 11-25. 10.1016/j.neuroscience.2017.08.053

Lopes, J. B., Bastos, J. R., Costa, R. B., Aguiar, D. C., & Moreira, F. A. (2020). The roles of cannabinoid CB1 and CB2 receptors in cocaine-induced behavioral sensitization and conditioned place preference in mice. Psychopharmacology (Berl), 237(2), 385-394. 10.1007/s00213-019-05370-5

McCoy, K. L. (2016). Interaction between Cannabinoid System and Toll-Like Receptors Controls Inflammation. Mediators Inflamm, 2016, 5831315. 10.1155/2016/5831315

Merighi, S., Gessi, S., Varani, K., Fazzi, D., Mirandola, P., & Borea, P. A. (2012). Cannabinoid CB(2) receptor attenuates morphine-induced inflammatory responses in activated microglial cells. Br J Pharmacol, 166(8), 2371-2385. 10.1111/j.1476-5381.2012.01948.x

Merighi, S., Gessi, S., Varani, K., Simioni, C., Fazzi, D., Mirandola, P., & Borea, P. A. (2012). Cannabinoid CB(2) receptors modulate ERK-1/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharide. Br J Pharmacol, 165(6), 1773-1788. 10.1111/j.1476-5381.2011.01673.x

Naguib, M., Xu, J. J., Diaz, P., Brown, D. L., Cogdell, D., Bie, B., & Hittelman, W. N. (2012). Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system. Anesth Analg, 114(5), 1104-1120. 10.1213/ANE.0b013e31824b0191

Perez, S. M., & Lodge, D. J. (2018). Convergent Inputs from the Hippocampus and Thalamus to the Nucleus Accumbens Regulate Dopamine Neuron Activity. J Neurosci, 38(50), 10607-10618. 10.1523/JNEUROSCI.2629-16.2018

Persidsky, Y., Fan, S., Dykstra, H., Reichenbach, N. L., Rom, S., & Ramirez, S. H. (2015). Activation of Cannabinoid Type Two Receptors (CB2) Diminish Inflammatory Responses in Macrophages and Brain Endothelium. J Neuroimmune Pharmacol, 10(2), 302-308. 10.1007/s11481-015-9591-3

Piomelli, D. (2003). The molecular logic of endocannabinoid signalling. Nat Rev Neurosci, 4(11), 873-884. 10.1038/nrn1247

Price, D. A., Martinez, A. A., Seillier, A., Koek, W., Acosta, Y., Fernandez, E., & Giuffrida, A. (2009). WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Eur J Neurosci, 29(11), 2177-2186. 10.1111/j.1460-9568.2009.06764.x

Rodriguez-Arias, M., Navarrete, F., Blanco-Gandia, M. C., Arenas, M. C., Aguilar, M. A., Bartoll-Andres, A., & Manzanares, J. (2015). Role of CB2 receptors in social and aggressive behavior in male mice. Psychopharmacology (Berl), 232(16), 3019-3031. 10.1007/s00213-015-3939-5

Rodriguez-Arias, M., Navarrete, F., Daza-Losada, M., Navarro, D., Aguilar, M. A., Berbel, P., & Manzanares, J. (2013). CB1 cannabinoid receptor-mediated aggressive behavior. Neuropharmacology, 75, 172-180. 10.1016/j.neuropharm.2013.07.013

Ronca, R. D., Myers, A. M., Ganea, D., Tuma, R. F., Walker, E. A., & Ward, S. J. (2015). A selective cannabinoid CB2 agonist attenuates damage and improves memory retention following stroke in mice. Life Sci, 138, 72-77. 10.1016/j.lfs.2015.05.005

Scudder, S. L., Baimel, C., Macdonald, E. E., & Carter, A. G. (2018). Hippocampal-Evoked Feedforward Inhibition in the Nucleus Accumbens. J Neurosci, 38(42), 9091-9104. 10.1523/JNEUROSCI.1971-18.2018

Stella, N. (2010). Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas. Glia, 58(9), 1017-1030. 10.1002/glia.20983

Tschop, J., Kasten, K. R., Nogueiras, R., Goetzman, H. S., Cave, C. M., England, L. G., & Caldwell, C. C. (2009). The cannabinoid receptor 2 is critical for the host response to sepsis. J Immunol, 183(1), 499-505. 10.4049/jimmunol.0900203

Volkow, N. D., Baler, R. D., Compton, W. M., & Weiss, S. R. (2014). Adverse health effects of marijuana use. N Engl J Med, 370(23), 2219-2227. 10.1056/NEJMra1402309

Wu, J., Bie, B., Yang, H., Xu, J. J., Brown, D. L., & Naguib, M. (2013). Activation of the CB2 receptor system reverses amyloid-induced memory deficiency. Neurobiol Aging, 34(3), 791-804. 10.1016/j.neurobiolaging.2012.06.011

Wu, Q., Ma, Y., Liu, Y., Wang, N., Zhao, X., & Wen, D. (2020). CB2R agonist JWH-133 attenuates chronic inflammation by restraining M1 macrophage polarization via Nrf2/HO-1 pathway in diet-induced obese mice. Life Sci, 260, 118424. 10.1016/j.lfs.2020.118424

Xi, Z. X., Peng, X. Q., Li, X., Song, R., Zhang, H. Y., Liu, Q. R., & Gardner, E. L. (2011). Brain cannabinoid CB(2) receptors modulate cocaine's actions in mice. Nat Neurosci, 14(9), 1160-1166. 10.1038/nn.2874

Zhang, H. Y., Gao, M., Liu, Q. R., Bi, G. H., Li, X., Yang, H. J., & Xi, Z. X. (2014). Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice. Proc Natl Acad Sci U S A, 111(46), E5007-5015. 10.1073/pnas.1413210111




How to Cite

MONTEIRO, R. F. M.; NASCIMENTO, M. V. L.; LIMA , K. T.; ALMEIDA, J. R. G.; ÁVILA, P. E. S.; BASTOS, G. de N. T. . Endocannabinoid System: behavioral modulation in murine models by Cannabinoids type 2 receptors. Research, Society and Development, [S. l.], v. 10, n. 13, p. e356101321491, 2021. DOI: 10.33448/rsd-v10i13.21491. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/21491. Acesso em: 7 dec. 2021.



Review Article